Yasheng Pharmaceutical (06855) was subscribed by Yang Dajun, executive director and chairman of the board of directors, for a total of 38,600 shares

Zhitong Finance App News, Yasheng Pharmaceutical (06855) announced that the company was informed by Dr. Yang Dajun, the company's executive director and chairman of the board of directors, that on September 23, 2026, September 24, 2026, and September 25, 2026, he subscribed for a total of 38,600 shares of the company's common shares on the market. The total cost was about HK$1.1571 million, and the average price was about HK$29.95 per share, accounting for about 0.01% of the total issued share capital of the Company.

After the subscription is completed, Dr. Yang will be deemed to have an interest in a total of 62.573 million shares, accounting for approximately 16.69% of the total issued share capital of the Company at the date of this announcement. According to Dr Yeung, the subscription matters showed his confidence in the company's future.